Figma Shares Indicated To Open $105/$110
Robert Thomas Freeman, the Chief Financial Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), recently sold a portion of his holdings in the company. According to the latest SEC filing, Freeman sold 6,744 shares of common stock on March 27, 2025. The shares were sold at a weighted-average price of $17.89 per share, resulting in a total transaction value of approximately $120,650. The transaction comes as ALHC trades near its 52-week high of $18.44, having delivered an impressive 269% return over the past year. InvestingPro analysis indicates the stock is currently in overbought territory.
The sale was made to cover tax withholding obligations related to the vesting of restricted stock units, as noted in the filing. Following this transaction, Freeman continues to hold 1,464,419 shares directly. Additionally, he has indirect ownership of 92,929 shares through FCO Holdings LLC, a limited liability company owned by an irrevocable trust of which Freeman is an indirect beneficiary. With a market capitalization of $3.51 billion and an overall Financial Health Score of GOOD according to InvestingPro, which offers 12 additional investment tips for ALHC subscribers.
In other recent news, Alignment Healthcare has reported strong financial results for the fourth quarter of 2024, surpassing analysts’ expectations. The company achieved an earnings per share (EPS) of -0.16, outperforming the forecast of -0.18, and reported revenue of $701.2 million, exceeding the anticipated $674.97 million. For the full year, revenue reached $2.7 billion, marking a 48% increase year-over-year. The company also achieved its first year of adjusted EBITDA profitability, a significant milestone. Piper Sandler has raised its price target for Alignment Healthcare to $21, maintaining an Overweight rating, citing the company’s scalable business model and high Star Ratings as key growth drivers. Similarly, Raymond (NSE:RYMD) James increased its price target to $19 and reiterated a Strong Buy rating, highlighting the company’s robust membership and revenue growth. Looking ahead, Alignment Healthcare has provided 2025 revenue guidance between $3.72 billion and $3.78 billion, with expectations of continued membership growth and improved profitability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.